Systems and methods for atrial fibrillation treatment and risk assessment

1. A method for providing an atrial fibrillation (AF) ablation treatment plan, comprising:

receiving imaging data for at least a portion of an atrial region of a subject's heart;

processing said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculating a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data;

identifying a cardiac tissue ablation target based on said metric; and

providing an AF treatment plan that includes said cardiac tissue ablation target as at least a portion of said AF treatment plan,

wherein said metric of spatial distribution is calculated for each of a plurality of subvolumes of said atrial regions of said subject's heart; and

wherein said plurality of subvolumes are between 1.3 mm and 1.7 mm in radius.

2. The method of claim 1 , wherein said receiving imaging data is receiving at least one of MRI, CT or PET imaging data.

3. The method of claim 1 , wherein said receiving imaging data is receiving late gadolinium enhancement magnetic resonance (LGE-MRI) data.

4. The method of claim 1 , further comprising identifying a plurality of cardiac tissue ablation targets based on said metric,

wherein said AF treatment plan further includes said plurality of cardiac tissue ablation targets.

5. The method of claim 1 , further comprising calculating a plurality of metrics of spatial distribution of tissue characterized as fibrotic tissue from said processing said imaging data.

6. The method of claim 1 , wherein said calculating a metric comprises calculating said metric for a portion of said tissue characterized as fibrotic tissue having a degree of fibrosis that falls within a predetermined range.

7. A method for providing an atrial fibrillation (AF) ablation treatment plan, comprising:

receiving imaging data for at least a portion of an atrial region of a subject's heart;

processing said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculating a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data;

identifying a cardiac tissue ablation target based on said metric;

providing an AF treatment plan that includes said cardiac tissue ablation target as at least a portion of said AF treatment plan; and

calculating a plurality of metrics of spatial distribution of tissue characterized as fibrotic tissue from said processing said imaging data,

wherein said plurality of metrics include at least density, clustering and complexity metrics.

8. A method for providing a risk assessment for atrial fibrillation (AF) and related health risks, as well as recurrence of atrial arrhythmia after ablation, comprising:

receiving imaging data for at least a portion of an atrial region of a subject's heart;

processing said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculating a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data for a plurality of localized regions within said portion of said atrial region of said subject's heart;

identifying a risk of at least one of developing atrial fibrillation, worsening atrial fibrillation, recurrence of atrial arrhythmias and fibrillation after ablation treatment, heart failure, or stroke based said metric of spatial distribution calculated for said plurality of localized regions,

wherein said metric of spatial distribution is calculated for each of a plurality of subvolumes of said atrial regions of said subject's heart; and

wherein said plurality of subvolumes are between 1.3 mm and 1.7 mm in radius.

9. The method of claim 8 , wherein said receiving imaging data is receiving at least one of MRI, CT or PET imaging data.

10. The method of claim 8 , wherein said receiving imaging data is receiving late gadolinium enhancement magnetic resonance (LGE-MRI) data.

11. A non-transitory computer-readable medium comprising computer-executable code for providing an atrial fibrillation (AF) ablation treatment plan, said computer-executable code comprising instructions that, when executed by the computer, causes the computer to:

receive imaging data for at least a portion of an atrial region of a subject's heart;

process said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculate a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data;

identify a cardiac tissue ablation target based on said metric; and

provide an AF treatment plan that includes said cardiac tissue ablation target as at least a portion of said AF treatment plan,

wherein said metric of spatial distribution is calculated for each of a plurality of subvolumes of said atrial regions of said subject's heart; and

wherein said plurality of subvolumes are between 1.3 mm and 1.7 mm in radius.

12. A non-transitory computer-readable medium comprising computer-executable code for providing a risk assessment for atrial fibrillation (AF) and related health risks, as well as recurrence of atrial arrhythmia after ablation when executed by the computer, causes the computer to:

receive imaging data for at least a portion of an atrial region of a subject's heart;

process said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculate a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data for a plurality of localized regions within said portion of said atrial region of said subject's heart;

identify a risk of at least one of developing atrial fibrillation, worsening atrial fibrillation, recurrence of atrial arrhythmias and fibrillation after ablation treatment, heart failure, or stroke based said metric of spatial distribution calculated for said plurality of localized regions,

wherein said metric of spatial distribution is calculated for each of a plurality of subvolumes of said atrial regions of said subject's heart; and

wherein said plurality of subvolumes are between 1.3 mm and 1.7 mm in radius.

13. A medical imaging system comprising a data processor configured to:

receive imaging data for at least a portion of an atrial region of a subject's heart;

process said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculate a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data for a plurality of localized regions within said portion of said atrial region of said subject's heart; and

provide at least one of a map based on said metric, at least one ablation target based on said metric, or a risk assessment for at least one of developing atrial fibrillation, worsening atrial fibrillation, recurrent atrial fibrillation, heart failure, or stroke based said metric,

wherein said metric of spatial distribution is calculated for each of a plurality of subvolumes of said atrial regions of said subject's heart; and

wherein said plurality of subvolumes are between 1.3 mm and 1.7 mm in radius.

14. An ablation system configured to receive data from the medical imaging system of claim 13 to provide guidance to a user for electro-anatomical mapping and/or ablation.

15. A method for providing a risk assessment for atrial fibrillation (AF) and related health risks, as well as recurrence of atrial arrhythmia after ablation, comprising:

receiving imaging data for at least a portion of an atrial region of a subject's heart;

processing said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculating a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data for a plurality of localized regions within said portion of said atrial region of said subject's heart;

identifying a risk of at least one of developing atrial fibrillation, worsening atrial fibrillation, recurrence of atrial arrhythmias and fibrillation after ablation treatment, heart failure, or stroke based said metric of spatial distribution calculated for said plurality of localized regions; and

calculating a plurality of metrics of spatial distribution of tissue characterized as fibrotic tissue from said processing said imaging data,

wherein said plurality of metrics include at least density, clustering and complexity metrics.

16. A non-transitory computer-readable medium comprising computer-executable code for providing an atrial fibrillation (AF) ablation treatment plan, said computer-executable code comprising instructions that, when executed by the computer, causes the computer to:

receive imaging data for at least a portion of an atrial region of a subject's heart;

process said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculate a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data;

identify a cardiac tissue ablation target based on said metric; and

provide an AF treatment plan that includes said cardiac tissue ablation target as at least a portion of said AF treatment plan; and

calculate a plurality of metrics of spatial distribution of tissue characterized as fibrotic tissue from said processing said imaging data,

wherein said plurality of metrics include at least density, clustering and complexity metrics.

17. A non-transitory computer-readable medium comprising computer-executable code for providing a risk assessment for atrial fibrillation (AF) and related health risks, as well as recurrence of atrial arrhythmia after ablation when executed by the computer, causes the computer to:

receive imaging data for at least a portion of an atrial region of a subject's heart;

process said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculate a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data for a plurality of localized regions within said portion of said atrial region of said subject's heart;

identify a risk of at least one of developing atrial fibrillation, worsening atrial fibrillation, recurrence of atrial arrhythmias and fibrillation after ablation treatment, heart failure, or stroke based said metric of spatial distribution calculated for said plurality of localized regions; and

calculate a plurality of metrics of spatial distribution of tissue characterized as fibrotic tissue from said processing said imaging data,

wherein said plurality of metrics include at least density, clustering and complexity metrics.

18. A medical imaging system comprising a data processor configured to:

receive imaging data for at least a portion of an atrial region of a subject's heart;

process said imaging data to characterize tissue as one of fibrotic tissue or non-fibrotic tissue;

calculate a metric of spatial distribution of at least a portion of said tissue characterized as fibrotic tissue from said processing said imaging data for a plurality of localized regions within said portion of said atrial region of said subject's heart; and

provide at least one of a map based on said metric, at least one ablation target based on said metric, or a risk assessment for at least one of developing atrial fibrillation, worsening atrial fibrillation, recurrent atrial fibrillation, heart failure, or stroke based said metric; and

calculate a plurality of metrics of spatial distribution of tissue characterized as fibrotic tissue from said processing said imaging data,

wherein said plurality of metrics include at least density, clustering and complexity metrics.